374505213	374505213	CD	B-NP	O
|	|	NN	I-NP	O
SMMC	SMMC	NN	I-NP	O
|	|	NN	I-NP	O
30420782	30420782	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
706155	706155	CD	B-NP	O
|	|	CC	I-NP	O
6/28/1998	6/28/1998	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
RENAL	RENAL	NNP	I-NP	I-protein
FAILURE	FAILURE	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/13/1998	10/13/1998	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/6/1998	4/6/1998	CD	B-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
RIGHT	RIGHT	NN	B-NP	O
GROIN	GROIN	NN	I-NP	O
ABSCESS	ABSCESS	NN	I-NP	O
.	.	.	O	O

PROBLEM	PROBLEM	NN	B-NP	O
LIST	LIST	NN	I-NP	O
:	:	:	O	O
-LRB-	-LRB-	NN	B-NP	B-protein
1	1	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
Status	Status	NNP	I-NP	O
post	post	VBD	B-VP	O
renal	renal	JJ	B-NP	O
transplantation	transplantation	NN	I-NP	O
,	,	,	O	O
living	live	VBG	B-VP	O
related	related	JJ	B-NP	O
donor	donor	NN	I-NP	O
April	April	NNP	B-NP	O
1997	1997	CD	I-NP	O
,	,	,	O	O
-LRB-	-LRB-	NN	B-NP	O
2	2	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
hypertension	hypertension	NN	I-NP	O
,	,	,	O	O
-LRB-	-LRB-	HYPH	B-NP	B-protein
3	3	CD	I-NP	I-protein
-RRB-	-RRB-	HYPH	I-NP	O
insulin-dependent	insulin-dependent	JJ	I-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
-LRB-	-LRB-	NN	B-NP	O
4	4	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
hypertension	hypertension	NN	I-NP	O
,	,	,	O	O
-LRB-	-LRB-	SYM	B-NP	O
5	5	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
hyperthyroidism	hyperthyroidism	NN	I-NP	O
,	,	,	O	O
-LRB-	-LRB-	NN	B-NP	O
6	6	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
hyperparathyroidism	hyperparathyroidism	NN	I-NP	O
,	,	,	O	O
-LRB-	-LRB-	NN	B-NP	O
7	7	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
hypertriglyceridemia	hypertriglyceridemia	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
42-year-old	42-year-old	JJ	I-NP	O
white	white	JJ	I-NP	O
man	man	NN	I-NP	O
who	who	WP	B-NP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
complaints	complaint	NNS	B-NP	O
of	of	IN	B-PP	O
fever	fever	NN	B-NP	O
to	to	TO	B-PP	O
103	103	CD	B-NP	O
and	and	CC	O	O
chills	chill	NNS	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
productive	productive	JJ	I-NP	O
cough	cough	NN	I-NP	O
and	and	CC	I-NP	O
groin	groin	NN	I-NP	O
pain	pain	NN	I-NP	O
lasting	last	VBG	B-VP	O
three	three	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
age	age	NN	B-NP	O
three	three	CD	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
diagnosed	diagnose	VBN	I-VP	O
with	with	IN	B-PP	O
Wilms	Wilms	NNP	B-NP	O
'	'	POS	B-NP	O
tumor	tumor	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
left	left	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
resected	resecte	VBN	I-VP	O
and	and	CC	O	O
subsequently	subsequently	RB	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
wide	wide	JJ	B-NP	O
field	field	NN	I-NP	O
radiation	radiation	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
,	,	,	O	O
thereafter	thereafter	RB	B-ADVP	O
developed	develop	VBD	B-VP	O
radiation-induced	radiation-induced	JJ	B-NP	O
tyroid	tyroid	JJ	I-NP	O
cancer	cancer	NN	I-NP	O
,	,	,	O	O
at	at	IN	B-PP	O
which	which	WDT	B-NP	O
time	time	NN	I-NP	O
he	he	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
subtotal	subtotal	JJ	B-NP	O
thyroidectomy	thyroidectomy	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
developed	develop	VBD	B-VP	O
radiation	radiation	NN	B-NP	O
nephritis	nephritis	NN	I-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
remaining	remain	VBG	I-NP	O
right	right	JJ	I-NP	O
kidney	kidney	NN	I-NP	O
and	and	CC	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
fibrosis	fibrosis	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
April	April	NNP	B-NP	O
of	of	IN	B-PP	O
1997	1997	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
underwent	undergo	VBD	B-VP	O
living	live	VBG	I-VP	O
related	related	JJ	B-NP	O
donor	donor	NN	I-NP	O
renal	renal	JJ	I-NP	O
transplantation	transplantation	NN	I-NP	O
for	for	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
point	point	NN	I-NP	O
CMV	CMV	NN	I-NP	O
antigen	antigen	NN	I-NP	O
negative	negative	JJ	B-ADJP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
donor	donor	NN	I-NP	O
kidney	kidney	NN	I-NP	O
was	be	VBD	B-VP	O
CMV	CMV	NN	B-NP	O
antigen	antigen	NN	I-NP	O
positive	positive	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
underwent	undergo	VBD	B-VP	O
an	an	DT	B-NP	O
uncomplicated	uncomplicated	JJ	I-NP	O
transplantation	transplantation	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
postoperative	postoperative	JJ	I-NP	O
course	course	NN	I-NP	O
was	be	VBD	B-VP	O
complicated	complicate	VBN	I-VP	O
by	by	IN	B-PP	O
cytomegalovirus	cytomegalovirus	NN	B-NP	O
infection	infection	NN	I-NP	O
,	,	,	O	O
presenting	present	VBG	B-VP	O
with	with	IN	B-PP	O
diarrhea	diarrhea	NN	B-NP	O
and	and	CC	O	O
requiring	require	VBG	B-VP	O
hospitalization	hospitalization	NN	B-NP	O
in	in	IN	B-PP	O
February	February	NNP	B-NP	O
1997	1997	CD	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
ganciclovir	ganciclovir	NN	B-NP	O
and	and	CC	O	O
subsequently	subsequently	RB	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
Cytovene	Cytovene	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
remained	remain	VBD	B-VP	O
healthy	healthy	JJ	B-ADJP	O
until	until	IN	B-PP	O
August	August	NNP	B-NP	O
1997	1997	CD	I-NP	O
,	,	,	O	O
at	at	IN	B-PP	O
which	which	WDT	B-NP	O
time	time	NN	I-NP	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
again	again	RB	I-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
recrudescence	recrudescence	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
cytomegalovirus	cytomegalovirus	NN	I-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
August	August	NNP	B-NP	O
1997	1997	CD	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
three-day	three-day	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
fever	fever	NN	B-NP	O
to	to	TO	B-PP	O
approximately	approximately	RB	B-NP	O
105	105	CD	I-NP	O
,	,	,	I-NP	O
anorexia	anorexia	NN	I-NP	O
,	,	,	O	O
dry	dry	JJ	B-NP	O
cough	cough	NN	I-NP	O
,	,	,	O	O
fatigue	fatigue	NN	B-NP	O
,	,	,	O	O
headache	headache	NN	B-NP	O
,	,	,	O	O
dizziness	dizziness	NN	B-NP	O
,	,	,	O	O
sweats	sweat	NNS	B-NP	O
,	,	,	O	O
nausea	nausea	NN	B-NP	O
and	and	CC	I-NP	O
dyspnea	dyspnea	NN	I-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
,	,	,	O	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
point	point	NN	I-NP	O
,	,	,	O	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
ganciclovir	ganciclovir	NN	B-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
his	his	PRP$	B-NP	O
fevers	fever	NNS	I-NP	O
persisted	persist	VBD	B-VP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
after	after	IN	B-PP	O
five	five	CD	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
therapy	therapy	NN	B-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
CMV	CMV	NN	I-NP	O
antigen	antigen	NN	I-NP	O
test	test	NN	I-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
his	his	PRP$	B-NP	B-cell_line
shell	shell	NN	I-NP	I-cell_line
vial	vial	JJ	I-NP	I-cell_line
cultures	culture	NNS	I-NP	I-cell_line
,	,	,	O	O
both	both	DT	B-NP	O
returned	return	VBD	B-VP	O
as	as	RB	B-PP	O
positive	positive	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
ganciclovir	ganciclovir	NN	B-NP	O
therapy	therapy	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
post	post	NN	I-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
until	until	IN	B-PP	O
April	April	NNP	B-NP	O
,	,	,	O	O
1997	1997	CD	B-NP	O
,	,	,	O	O
at	at	IN	B-PP	O
which	which	WDT	B-NP	O
time	time	NN	B-NP	O
his	his	PRP$	B-NP	O
peripherally	peripherally	RB	I-NP	O
inserted	insert	VBN	I-NP	O
catheter	catheter	NN	I-NP	O
was	be	VBD	B-VP	O
removed	remove	VBN	I-VP	O
.	.	.	O	O

Subsequently	Subsequently	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
healthy	healthy	JJ	B-ADJP	O
for	for	IN	B-PP	O
approximately	approximately	RB	B-NP	O
four	four	CD	I-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
on	on	IN	B-PP	O
June	June	NNP	B-NP	O
,	,	,	O	O
1998	1998	CD	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
noted	note	VBD	B-VP	O
a	a	DT	B-NP	O
groin	groin	NN	I-NP	O
lump	lump	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
right	right	NN	I-NP	O
.	.	.	O	O

From	From	IN	B-PP	O
June	June	NNP	B-NP	O
,	,	,	O	O
1998	1998	CD	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
noted	note	VBD	B-VP	O
feeling	feel	VBG	I-VP	O
worse	worse	JJR	B-ADJP	O
with	with	IN	B-PP	O
fevers	fever	NNS	B-NP	O
and	and	CC	I-NP	O
chills	chill	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
productive	productive	JJ	I-NP	O
cough	cough	NN	I-NP	O
beginning	begin	VBG	B-PP	O
on	on	IN	B-PP	O
September	September	NNP	B-NP	O
,	,	,	O	O
1998	1998	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
groin	groin	NN	I-NP	O
lump	lump	NN	I-NP	O
,	,	,	O	O
subsequently	subsequently	RB	B-ADVP	O
,	,	,	O	O
became	become	VBD	B-VP	O
painful	painful	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
he	he	PRP	B-NP	O
passed	pass	VBD	B-VP	O
several	several	JJ	B-NP	O
loose	loose	JJ	I-NP	O
bowel	bowel	NN	I-NP	O
movements	movement	NNS	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
-LRB-	-LRB-	NNP	B-NP	O
1	1	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Wilms	Wilms	NNP	I-NP	O
'	'	POS	B-NP	O
tumor	tumor	NN	I-NP	O
,	,	,	O	O
-LRB-	-LRB-	NN	B-NP	B-protein
2	2	CD	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
status	status	NN	I-NP	O
post	post	NN	I-NP	O
left	leave	VBD	B-VP	O
nephrectomy	nephrectomy	NN	B-NP	O
with	with	IN	B-PP	O
wide	wide	JJ	B-NP	O
field	field	NN	I-NP	O
radiation	radiation	NN	I-NP	O
therapy	therapy	NN	I-NP	O
,	,	,	O	O
-LRB-	-LRB-	NN	B-NP	O
3	3	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
NCH	NCH	NN	I-NP	O
renal	renal	JJ	I-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
living	live	VBG	B-VP	O
related	related	JJ	B-NP	O
donor	donor	NN	I-NP	O
renal	renal	JJ	I-NP	O
transplant	transplant	NN	I-NP	O
from	from	IN	B-PP	O
father	father	NN	B-NP	O
in	in	IN	B-PP	O
April	April	NNP	B-NP	O
1997	1997	CD	I-NP	O
,	,	,	O	O
-LRB-	-LRB-	SYM	B-NP	O
4	4	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
hypertension	hypertension	NN	I-NP	O
,	,	,	O	O
-LRB-	-LRB-	SYM	B-NP	B-protein
5	5	CD	I-NP	I-protein
-RRB-	-RRB-	HYPH	I-NP	O
insulin-dependent	insulin-dependent	JJ	I-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
-LRB-	-LRB-	NN	B-NP	O
6	6	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
hypertension	hypertension	NN	I-NP	O
,	,	,	O	O
-LRB-	-LRB-	NN	B-NP	O
7	7	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
hyperthyroid	hyperthyroid	NN	I-NP	O
,	,	,	O	O
-LRB-	-LRB-	NN	B-NP	O
8	8	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
hyperparathyroid	hyperparathyroid	NN	I-NP	O
,	,	,	O	O
-LRB-	-LRB-	NN	B-NP	O
9	9	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
hypertriglyceridemia	hypertriglyceridemia	NN	I-NP	O
,	,	,	O	O
-LRB-	-LRB-	NN	B-NP	O
10	10	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
gout	gout	NN	I-NP	O
,	,	,	O	O
-LRB-	-LRB-	NN	B-NP	O
11	11	CD	I-NP	O
-RRB-	-RRB-	:	O	O
CMV	CMV	NN	B-NP	O
infection	infection	NN	I-NP	O
in	in	IN	B-PP	O
February	February	NNP	B-NP	O
1997	1997	CD	I-NP	O
and	and	CC	O	O
August	August	NNP	B-NP	O
1997	1997	CD	I-NP	O
,	,	,	O	O
-LRB-	-LRB-	NN	B-NP	O
12	12	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
perirectal	perirectal	JJ	B-NP	O
abscess	abscess	NN	I-NP	O
,	,	,	O	O
-LRB-	-LRB-	SYM	B-NP	O
13	13	CD	I-NP	O
-RRB-	-RRB-	SYM	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
spontaneously	spontaneously	RB	B-VP	O
converted	convert	VBN	I-VP	O
in	in	IN	B-PP	O
October	October	NNP	B-NP	O
1998	1998	CD	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
NO	NO	NN	B-NP	O
KNOWN	KNOWN	NN	I-NP	O
DRUG	DRUG	NN	I-NP	O
ALLERGIES	ALLERGIES	NN	I-NP	O
.	.	.	O	O

ADMISSION	ADMISSION	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Synthroid	Synthroid	JJ	B-NP	O
150	150	CD	I-NP	O
mcg	mcg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
NPH	NPH	NN	B-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
14	14	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
q.a.m.	q.a.m.	RB	B-ADVP	O
,	,	,	O	O
regular	regular	JJ	B-NP	O
insulin	insulin	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
,	,	,	O	O
nadolol	nadolol	NN	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
Prednisone	Prednisone	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
Neoral	Neoral	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
CellCept	CellCept	NNP	B-NP	O
1	1	CD	I-NP	O
g	g	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
,	,	,	O	O
Axid	Axid	NNP	B-NP	O
150	150	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
,	,	,	O	O
Coumadin	Coumadin	NN	B-NP	O
4	4	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
SOCIAL	SOCIAL	NN	I-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
lives	live	VBZ	B-VP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
wife	wife	NN	I-NP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
four	four	CD	B-NP	O
children	child	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
alcohol	alcohol	NN	B-NP	O
or	or	CC	I-NP	O
tobacco	tobacco	NN	I-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
cancer	cancer	NN	B-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
pleasant	pleasant	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
ill-appearing	ill-appearing	JJ	B-NP	O
man	man	NN	I-NP	O
in	in	IN	B-PP	O
some	some	DT	B-NP	O
respiratory	respiratory	JJ	I-NP	O
distress	distress	NN	I-NP	O
,	,	,	O	O
lying	lie	VBG	B-VP	O
in	in	IN	B-PP	O
bed	bed	NN	B-NP	O
.	.	.	O	O

Temperature	Temperature	NN	B-NP	O
is	be	VBZ	B-VP	O
103	103	CD	B-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
70	70	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
160/80	160/80	CD	I-NP	O
,	,	,	O	O
respirations	respiration	NNS	B-NP	O
26	26	CD	B-NP	O
,	,	,	O	O
oxygen	oxygen	NN	B-NP	O
saturation	saturation	NN	I-NP	O
90	90	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
4	4	CD	B-NP	O
L	L	NN	I-NP	O
oxygen	oxygen	NN	I-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
examination	examination	NN	I-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
cushingoid	cushingoid	JJ	B-NP	O
facies	facy	NNS	I-NP	O
and	and	CC	O	O
flushing	flushing	NN	B-NP	O
was	be	VBD	B-VP	O
evident	evident	JJ	B-ADJP	O
.	.	.	O	O

No	No	DT	B-NP	O
lymphadenopathy	lymphadenopathy	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
neck	neck	NN	I-NP	O
was	be	VBD	B-VP	O
supple	supple	JJ	B-NP	O
,	,	,	I-NP	O
mucous	mucous	JJ	I-NP	O
membranes	membrane	NNS	I-NP	O
moist	moist	NN	I-NP	O
and	and	CC	I-NP	O
sclera	sclera	NN	I-NP	O
were	be	VBD	B-VP	O
anicteric	anicteric	JJ	B-ADJP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
examination	examination	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
crackles	crackle	NNS	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
right	right	NN	I-NP	O
to	to	TO	B-PP	O
half	half	JJ	B-NP	O
way	way	NN	I-NP	O
up	up	IN	B-ADVP	O
.	.	.	O	O

Heart	Heart	NN	B-NP	O
examination	examination	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
noisy	noisy	JJ	I-NP	O
precordium	precordium	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
prominent	prominent	JJ	I-NP	O
T2	T2	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
2/6	2/6	CD	I-NP	O
systolic	systolic	JJ	I-NP	O
ejection	ejection	NN	I-NP	O
murmur	murmur	NN	I-NP	O
.	.	.	O	O

Abdominal	Abdominal	JJ	B-NP	O
examination	examination	NN	I-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Extremity	Extremity	NN	B-NP	O
examination	examination	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
some	some	DT	B-NP	O
slight	slight	JJ	I-NP	O
swelling	swelling	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
lower	low	JJR	I-NP	O
extremities	extremity	NNS	I-NP	O
.	.	.	O	O

Cutaneous	Cutaneous	JJ	B-NP	O
examination	examination	NN	I-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
thin	thin	JJ	B-NP	O
subcutaneous	subcutaneous	JJ	I-NP	O
tissues	tissue	NNS	I-NP	O
and	and	CC	O	O
development	development	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
buffalo	buffalo	NN	I-NP	O
hump	hump	NN	I-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
White	White	JJ	B-NP	O
count	count	NN	I-NP	O
of	of	IN	B-PP	O
11.3	11.3	CD	B-NP	O
with	with	IN	B-PP	O
46	46	CD	B-NP	O
polys	poly	NNS	I-NP	O
,	,	,	O	O
36	36	CD	B-NP	O
lymphocytes	lymphocyte	NNS	I-NP	O
and	and	CC	O	O
7	7	CD	B-NP	O
bands	band	NNS	I-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
was	be	VBD	B-VP	I-protein
32.4	32.4	CD	B-NP	I-protein
and	and	CC	O	O
platelets	platelet	NNS	B-NP	B-cell_type
were	be	VBD	B-VP	O
143	143	CD	B-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
.	.	.	O	O

Coagulation	Coagulation	NN	B-NP	O
studies	study	NNS	I-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
prothrombin	prothrombin	NN	I-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
15.8	15.8	CD	B-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
INR	INR	NN	I-NP	B-protein
of	of	IN	B-PP	O
1.8	1.8	CD	B-NP	O
.	.	.	O	O

Electrolytes	Electrolyte	NNS	B-NP	O
were	be	VBD	B-VP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
urea	urea	NN	I-NP	O
nitrogen	nitrogen	NN	I-NP	O
was	be	VBD	B-VP	O
39	39	CD	B-NP	O
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
was	be	VBD	B-VP	O
2.5	2.5	CD	B-NP	O
,	,	,	O	O
glucose	glucose	NN	B-NP	O
was	be	VBD	B-VP	O
85	85	CD	B-NP	O
,	,	,	O	O
calcium	calcium	NN	B-NP	O
10.2	10.2	CD	I-NP	O
.	.	.	O	O

Liver	Liver	NN	B-NP	O
function	function	NN	I-NP	O
tests	test	NNS	I-NP	O
revealed	reveal	VBD	B-VP	O
an	an	DT	B-NP	O
alkaline	alkaline	NN	I-NP	B-protein
phosphatase	phosphatase	NN	I-NP	I-protein
of	of	IN	B-PP	O
342	342	CD	B-NP	O
,	,	,	O	O
total	total	JJ	B-NP	O
protein	protein	NN	I-NP	O
was	be	VBD	B-VP	O
7.9	7.9	CD	B-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
albumin	albumin	NN	I-NP	O
of	of	IN	B-PP	O
3.9	3.9	CD	B-NP	O
.	.	.	O	O

Cholesterol	Cholesterol	NN	B-NP	O
was	be	VBD	B-VP	O
194	194	CD	B-NP	O
,	,	,	O	O
triglycerides	triglyceride	NNS	B-NP	O
were	be	VBD	B-VP	O
249	249	CD	B-NP	O
.	.	.	O	O

Cyclosporine	Cyclosporine	NN	B-NP	O
level	level	NN	I-NP	O
was	be	VBD	B-VP	O
303	303	CD	B-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

INFECTIOUS	INFECTIOUS	NNP	B-NP	O
DISEASES	DISEASES	NNP	I-NP	O
:	:	:	O	O
Surgery	Surgery	NN	B-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
and	and	CC	O	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
groin	groin	NN	I-NP	O
abscess	abscess	NN	I-NP	O
was	be	VBD	B-VP	O
drained	drain	VBN	I-VP	O
and	and	CC	O	O
a	a	DT	B-NP	O
wick	wick	NN	I-NP	O
was	be	VBD	B-VP	O
inserted	insert	VBN	I-VP	O
.	.	.	O	O

This	This	DT	B-NP	O
wound	wound	NN	I-NP	O
was	be	VBD	B-VP	O
dressed	dress	VBN	I-VP	O
and	and	CC	O	O
continued	continue	VBN	B-NP	O
care	care	NN	I-NP	O
was	be	VBD	B-VP	O
preformed	preforme	VBN	I-VP	O
by	by	IN	B-PP	O
nursing	nurse	VBG	B-VP	O
staff	staff	NN	B-NP	O
.	.	.	O	O

Blood	Blood	NN	B-NP	O
cultures	culture	NNS	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
revealed	reveal	VBD	B-VP	O
no	no	DT	B-NP	O
growth	growth	NN	I-NP	O
and	and	CC	B-PP	O
on	on	IN	B-PP	O
hospital	hospital	NN	B-NP	O
day	day	NN	I-NP	O
two	two	CD	B-NP	O
revealed	reveal	VBD	B-VP	O
no	no	DT	B-NP	O
growth	growth	NN	I-NP	O
.	.	.	O	O

Wound	Wound	JJ	B-NP	B-cell_line
cultures	culture	NNS	I-NP	I-cell_line
revealed	reveal	VBD	B-VP	O
few	few	JJ	B-NP	O
coagulase	coagulase	NN	I-NP	O
,	,	,	O	O
negative	negative	JJ	B-NP	O
staph	staph	NN	I-NP	O
.	.	.	O	O

Antibiotics	Antibiotic	NNS	B-NP	O
were	be	VBD	B-VP	O
initiated	initiate	VBN	I-VP	O
,	,	,	O	O
first	first	JJ	B-NP	O
vancomycin	vancomycin	NN	I-NP	O
,	,	,	O	O
gentamicin	gentamicin	NN	B-NP	O
and	and	CC	I-NP	O
Flagyl	Flagyl	NN	I-NP	O
were	be	VBD	B-VP	O
initiated	initiate	VBN	I-VP	O
,	,	,	O	O
however	however	RB	B-NP	O
gentamycin	gentamycin	NN	I-NP	O
was	be	VBD	B-VP	O
subsequently	subsequently	RB	I-VP	O
discontinued	discontinue	VBN	I-VP	O
and	and	CC	O	O
ceftazidime	ceftazidime	NN	B-NP	O
was	be	VBD	B-VP	O
initiated	initiate	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
one	one	CD	B-NP	O
fever	fever	NN	I-NP	O
spike	spike	NN	I-NP	O
on	on	IN	B-PP	O
hospital	hospital	NN	B-NP	O
day	day	NN	I-NP	O
one	one	CD	B-NP	O
to	to	TO	I-NP	O
101.9	101.9	CD	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
subsequently	subsequently	RB	B-ADVP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
fever	fever	NN	I-NP	O
spikes	spike	VBZ	B-VP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
on	on	IN	B-PP	O
hospital	hospital	NN	B-NP	O
day	day	NN	I-NP	O
three	three	CD	B-NP	O
Levaquin	Levaquin	NN	I-NP	O
was	be	VBD	B-VP	O
initiated	initiate	VBN	I-VP	O
and	and	CC	O	O
intravenous	intravenous	JJ	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
were	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
until	until	IN	B-PP	O
hospital	hospital	NN	B-NP	O
day	day	NN	I-NP	O
four	four	CD	B-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
that	that	DT	B-NP	O
point	point	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
afebrile	afebrile	RB	B-ADVP	O
for	for	IN	B-PP	O
48	48	CD	B-NP	O
hours	hour	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
decision	decision	NN	I-NP	O
was	be	VBD	B-VP	O
made	make	VBN	I-VP	O
to	to	TO	B-VP	O
switch	switch	VB	I-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
to	to	TO	B-PP	O
oral	oral	JJ	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
Levaquin	Levaquin	NNP	B-NP	O
and	and	CC	I-NP	O
Augmentin	Augmentin	NNP	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
defervesce	defervesce	VB	I-VP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
breathing	breathing	NN	I-NP	O
improved	improve	VBD	B-VP	O
,	,	,	O	O
the	the	DT	B-NP	O
pain	pain	NN	I-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
right	right	JJ	I-NP	O
groin	groin	NN	I-NP	O
improved	improve	VBD	B-VP	O
,	,	,	O	O
dressing	dress	VBG	B-NP	O
changes	change	NNS	I-NP	O
were	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
remained	remain	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
for	for	IN	B-PP	O
more	more	JJR	B-NP	O
than	than	IN	I-NP	O
24	24	CD	I-NP	O
hours	hour	NNS	I-NP	O
after	after	IN	B-PP	O
initiating	initiate	VBG	B-VP	O
oral	oral	JJ	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

CARDIOVASCULAR	CARDIOVASCULAR	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
nadolol	nadolol	NN	B-NP	O
,	,	,	O	O
recently	recently	RB	B-ADVP	O
requiring	require	VBG	B-VP	O
a	a	DT	B-NP	O
doubling	doubling	NN	I-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
dose	dose	NN	I-NP	O
from	from	IN	B-PP	O
40	40	CD	B-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
to	to	TO	B-PP	O
80	80	CD	B-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
and	and	CC	O	O
placed	place	VBN	B-VP	O
on	on	IN	B-PP	O
80	80	CD	B-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
of	of	IN	B-PP	O
nadolol	nadolol	NN	B-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
run	run	VB	I-VP	O
up	up	IN	B-NP	O
to	to	TO	I-NP	O
170	170	CD	I-NP	O
systolic	systolic	JJ	I-NP	O
and	and	CC	I-NP	O
up	up	RB	I-NP	O
to	to	TO	B-PP	O
110	110	CD	B-NP	O
diastolic	diastolic	JJ	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
decision	decision	NN	I-NP	O
was	be	VBD	B-VP	O
made	make	VBN	I-VP	O
to	to	TO	B-VP	O
initiate	initiate	VB	I-VP	O
a	a	DT	B-NP	O
second	second	JJ	I-NP	O
antihypertensive	antihypertensive	JJ	I-NP	O
medication	medication	NN	I-NP	O
and	and	CC	I-NP	O
nifedipine	nifedipine	NN	I-NP	O
XL	XL	NN	I-NP	O
was	be	VBD	B-VP	O
chosen	choose	VBN	I-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
for	for	IN	B-PP	O
two	two	CD	B-NP	O
days	day	NNS	I-NP	O
at	at	IN	B-PP	O
30	30	CD	B-NP	O
mg	mg	NN	I-NP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
medication	medication	NN	I-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
subsequently	subsequently	RB	B-ADVP	O
stabilized	stabilize	VBD	B-VP	O
at	at	IN	B-PP	O
130/80	130/80	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
carries	carry	VBZ	B-VP	O
a	a	DT	B-NP	O
diagnosis	diagnosis	NN	I-NP	O
of	of	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
hypertension	hypertension	NN	I-NP	O
,	,	,	O	O
presumed	presume	VBN	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
February	February	NNP	I-NP	O
1997	1997	CD	I-NP	O
,	,	,	O	O
results	result	NNS	B-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
pressure	pressure	NN	I-NP	O
gradient	gradient	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
arterial	arterial	JJ	I-NP	O
system	system	NN	I-NP	O
,	,	,	B-PP	O
and	and	CC	I-PP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
a	a	DT	B-NP	O
subsequent	subsequent	JJ	I-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
to	to	TO	I-VP	O
assess	assess	VB	I-VP	O
left	left	JJ	B-NP	O
ventricular	ventricular	JJ	I-NP	O
function	function	NN	I-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
vascular	vascular	JJ	I-NP	O
status	status	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
results	result	NNS	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
tricuspid	tricuspid	NN	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
+	+	SYM	I-NP	O
mitral	mitral	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
,	,	,	O	O
unchanged	unchanged	JJ	B-ADJP	O
from	from	IN	B-PP	O
prior	prior	JJ	B-NP	O
studies	study	NNS	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
arterial	arterial	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
approximately	approximately	RB	B-NP	O
45	45	CD	I-NP	O
mmHg	mmHg	NN	I-NP	O
,	,	,	O	O
also	also	RB	B-ADVP	O
not	not	RB	B-VP	O
notably	notably	RB	I-VP	O
changed	change	VBN	I-VP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

PULMONARY	PULMONARY	NN	B-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
reported	report	VBD	B-VP	O
a	a	DT	B-NP	O
productive	productive	JJ	I-NP	O
cough	cough	NN	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
addition	addition	NN	B-NP	O
to	to	TO	B-PP	O
difficulty	difficulty	NN	B-NP	O
breathing	breathing	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
chest	chest	NN	I-NP	O
radiogram	radiogram	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
revealed	reveal	VBD	B-VP	O
possibility	possibility	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
sided	sided	JJ	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
process	process	NN	I-NP	O
,	,	,	O	O
corroborated	corroborate	VBN	B-VP	O
on	on	IN	B-PP	O
examination	examination	NN	B-NP	O
by	by	IN	B-PP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
crackles	crackle	NNS	B-NP	O
half	half	DT	B-NP	O
way	way	NN	I-NP	O
up	up	RP	O	O
.	.	.	O	O

The	The	DT	B-NP	O
decision	decision	NN	I-NP	O
was	be	VBD	B-VP	O
made	make	VBN	I-VP	O
to	to	TO	B-VP	O
rule	rule	VB	I-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
another	another	DT	B-NP	O
flare	flare	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
CMV	CMV	NN	I-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

Studies	Study	NNS	B-NP	O
for	for	IN	B-PP	O
CMV	CMV	NN	B-NP	B-protein
antigen	antigen	NN	I-NP	I-protein
and	and	CC	I-NP	O
CMV	CMV	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
buffy	buffy	NN	I-NP	O
coat	coat	NN	I-NP	O
were	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
and	and	CC	O	O
the	the	DT	B-NP	O
final	final	JJ	I-NP	O
results	result	NNS	I-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
positive	positive	JJ	I-NP	B-protein
CMV	CMV	NN	I-NP	I-protein
antigen	antigen	NN	I-NP	I-protein
,	,	,	O	O
but	but	CC	O	O
a	a	DT	B-NP	O
negative	negative	JJ	I-NP	O
buffy	buffy	JJ	I-NP	O
coat	coat	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
status	status	NN	I-NP	O
improved	improve	VBN	B-VP	O
on	on	IN	B-PP	O
oxygen	oxygen	NN	B-NP	O
and	and	CC	B-PP	O
on	on	IN	B-PP	O
intravenous	intravenous	JJ	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
induced	induce	VBN	I-NP	O
sputum	sputum	NN	I-NP	O
sample	sample	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
and	and	CC	O	O
studies	study	NNS	B-NP	O
were	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
for	for	IN	B-PP	O
atypical	atypical	JJ	B-NP	O
organisms	organism	NNS	I-NP	O
including	include	VBG	B-PP	O
CPT	CPT	NN	B-NP	B-protein
,	,	,	O	O
fungi	fungi	NN	B-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
addition	addition	NN	B-NP	O
to	to	TO	B-PP	O
bacteria	bacteria	NNS	B-NP	O
.	.	.	O	O

All	All	PDT	B-NP	O
these	these	DT	I-NP	O
studies	study	NNS	I-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
Legionella	Legionella	NN	B-NP	B-protein
antigen	antigen	NN	I-NP	I-protein
was	be	VBD	B-VP	O
also	also	RB	B-ADVP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Prior	Prior	RB	B-ADVP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
status	status	NN	I-NP	O
had	have	VBD	B-VP	O
returned	return	VBN	I-VP	O
to	to	TO	B-PP	O
baseline	baseline	NN	B-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
entirely	entirely	RB	I-VP	O
resolved	resolve	VBN	I-VP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

GASTROINTESTINAL	GASTROINTESTINAL	NN	B-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
reported	report	VBD	B-VP	O
multiple	multiple	JJ	B-NP	O
loose	loose	JJ	I-NP	O
bowel	bowel	NN	I-NP	O
movements	movement	NNS	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
this	this	DT	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
continue	continue	VB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
an	an	DT	B-NP	O
issue	issue	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
regained	regain	VBD	B-VP	O
his	his	PRP$	B-NP	O
appetite	appetite	NN	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

HEMATOLOGIC	HEMATOLOGIC	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
anticoagulation	anticoagulation	NN	I-NP	O
for	for	IN	B-PP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
at	at	IN	B-PP	O
4	4	CD	B-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
INR	INR	NN	I-NP	O
remaining	remain	VBG	B-VP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
goal	goal	NN	I-NP	O
parameters	parameter	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
set	set	VBN	I-VP	O
at	at	IN	B-PP	O
1.6-2	1.6-2	CD	B-NP	O
.0	.0	CD	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
however	however	RB	B-ADVP	O
,	,	,	O	O
has	have	VBZ	B-VP	O
recently	recently	RB	I-VP	O
spontaneously	spontaneously	RB	I-VP	O
converted	convert	VBN	I-VP	O
to	to	TO	B-PP	O
sinus	sinus	NN	B-NP	O
rhythm	rhythm	NN	I-NP	O
and	and	CC	B-PP	O
throughout	throughout	IN	B-PP	O
his	his	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
remained	remain	VBD	B-VP	O
in	in	IN	B-PP	O
sinus	sinus	NN	B-NP	O
rhythm	rhythm	NN	I-NP	O
with	with	IN	B-PP	O
continuous	continuous	JJ	B-NP	O
monitoring	monitoring	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

RENAL	RENAL	NN	B-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
creatinine	creatinine	NN	I-NP	O
level	level	NN	I-NP	O
was	be	VBD	B-VP	O
2.5	2.5	CD	B-NP	O
and	and	CC	O	O
remained	remain	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
throughout	throughout	IN	B-PP	O
his	his	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
cyclosporine	cyclosporine	NN	I-NP	O
level	level	NN	I-NP	O
was	be	VBD	B-VP	O
303	303	CD	B-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
hospital	hospital	NN	B-NP	O
day	day	NN	I-NP	O
four	four	CD	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
700	700	CD	B-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
this	this	DT	B-NP	O
determined	determine	VBN	B-VP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
level	level	NN	I-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
drawn	draw	VBN	I-VP	O
shortly	shortly	RB	B-ADVP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
taken	take	VBN	I-VP	O
the	the	DT	B-NP	O
cyclosporine	cyclosporine	NN	I-NP	O
.	.	.	O	O

During	During	IN	B-PP	O
his	his	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
,	,	,	O	O
vancomycin	vancomycin	NN	B-NP	O
levels	level	NNS	I-NP	O
were	be	VBD	B-VP	O
followed	follow	VBN	I-VP	O
.	.	.	O	O

These	These	DT	B-NP	O
levels	level	NNS	I-NP	O
reached	reach	VBD	B-VP	O
a	a	DT	B-NP	O
maximum	maximum	NN	I-NP	O
of	of	IN	B-PP	O
19.8	19.8	CD	B-NP	O
on	on	IN	B-PP	O
hospital	hospital	NN	B-NP	O
day	day	NN	I-NP	O
four	four	CD	B-NP	O
,	,	,	O	O
at	at	IN	B-PP	O
which	which	WDT	B-NP	O
time	time	NN	I-NP	O
intravenous	intravenous	JJ	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
were	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

ENDOCRINE	ENDOCRINE	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
carries	carry	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
endocrine	endocrine	JJ	I-NP	O
issues	issue	NNS	I-NP	O
including	include	VBG	B-PP	O
hypercalcemia	hypercalcemia	NN	B-NP	O
and	and	CC	I-NP	O
hyperparathyroidism	hyperparathyroidism	NN	I-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
hyperthyroidism	hyperthyroidism	NN	B-NP	O
on	on	IN	B-PP	O
thyroid	thyroid	JJ	B-NP	O
replacement	replacement	NN	I-NP	O
therapy	therapy	NN	I-NP	O
following	follow	VBG	B-PP	O
subtotal	subtotal	JJ	B-NP	O
thyroidectomy	thyroidectomy	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
possibility	possibility	NN	B-NP	O
of	of	IN	B-PP	O
mineral	mineral	JJ	B-NP	O
corticoid	corticoid	NN	I-NP	O
deficiency	deficiency	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
Endocrine	Endocrine	JJ	I-NP	O
Team	Team	NN	I-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
.	.	.	O	O

Thyroid	Thyroid	JJ	B-NP	O
studies	study	NNS	I-NP	O
and	and	CC	O	O
parathyroid	parathyroid	JJ	B-NP	O
studies	study	NNS	I-NP	O
were	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
and	and	CC	O	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
TSH	TSH	NN	I-NP	O
of	of	IN	B-PP	O
0.02	0.02	CD	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
T4	T4	NN	I-NP	O
of	of	IN	B-PP	O
6.0	6.0	CD	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
THPR	THPR	NN	I-NP	B-protein
of	of	IN	B-PP	O
1.47	1.47	CD	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
parathyroid	parathyroid	NN	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
25	25	CD	I-NP	O
vitamin	vitamin	NN	I-NP	O
D	D	NN	I-NP	O
and	and	CC	O	O
25	25	CD	B-NP	O
vitamin	vitamin	NN	I-NP	O
D	D	NN	I-NP	O
were	be	VBD	B-VP	O
still	still	RB	I-VP	O
pending	pende	VBG	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
Endocrine	Endocrine	NNP	I-NP	O
Team	Team	NNP	I-NP	O
recommended	recommend	VBD	B-VP	O
decreasing	decrease	VBG	I-VP	O
his	his	PRP$	B-NP	O
Synthroid	Synthroid	JJ	I-NP	O
dose	dose	NN	I-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
125	125	CD	B-NP	O
mcg	mcg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
they	they	PRP	B-NP	O
recommended	recommend	VBD	B-VP	O
a	a	DT	B-NP	O
bone	bone	NN	I-NP	O
densitometry	densitometry	NN	I-NP	O
study	study	NN	I-NP	O
for	for	IN	B-PP	O
evaluation	evaluation	NN	B-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
bone	bone	NN	I-NP	O
mass	mass	NN	I-NP	O
following	follow	VBG	B-PP	O
chronic	chronic	JJ	B-NP	O
maintenance	maintenance	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
steroid	steroid	NN	I-NP	O
therapy	therapy	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
hyperparathyroidism	hyperparathyroidism	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
team	team	NN	I-NP	O
thought	think	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
previous	previous	JJ	I-NP	O
question	question	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
mineral	mineral	JJ	I-NP	O
corticoid	corticoid	NN	I-NP	O
deficiency	deficiency	NN	I-NP	O
was	be	VBD	B-VP	O
likely	likely	RB	B-ADJP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
prior	prior	JJ	I-NP	O
Cozaar	Cozaar	NNP	I-NP	O
therapy	therapy	NN	I-NP	O
.	.	.	O	O

They	They	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
fell	fell	VB	I-VP	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
necessary	necessary	JJ	B-ADJP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
point	point	NN	I-NP	O
to	to	TO	B-VP	O
preform	preform	VB	I-VP	O
a	a	DT	B-NP	O
cortizone	cortizone	NN	I-NP	O
stimulation	stimulation	NN	I-NP	O
study	study	NN	I-NP	O
or	or	CC	O	O
to	to	TO	B-VP	O
further	further	RB	I-VP	O
assess	assess	VB	I-VP	O
this	this	DT	B-NP	O
possibility	possibility	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
mineral	mineral	JJ	I-NP	O
corticoid	corticoid	NN	I-NP	O
deficiency	deficiency	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Augmentin	Augmentin	NN	B-NP	O
250/125	250/125	CD	I-NP	O
mg	mg	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
Levaquin	Levaquin	NNP	B-NP	O
250	250	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
CellCept	CellCept	NNP	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
Neoral	Neoral	JJ	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
Prednisone	Prednisone	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
Synthroid	Synthroid	NNP	B-NP	O
125	125	CD	I-NP	O
mcg	mcg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
INP	INP	NN	B-NP	O
insulin	insulin	NN	I-NP	O
14	14	CD	B-NP	O
units	unit	NNS	I-NP	O
subcu	subcu	NN	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
,	,	,	O	O
regular	regular	JJ	B-NP	O
insulin	insulin	NN	I-NP	O
subcu	subcu	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
,	,	,	O	O
Axid	Axid	NN	B-NP	O
150	150	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
nadolol	nadolol	NN	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
nifedipine	nifedipine	NN	B-NP	O
XL	XL	NN	I-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
Coumadin	Coumadin	NN	B-NP	O
4	4	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
iron	iron	NN	B-NP	O
sulfate	sulfate	NN	I-NP	O
300	300	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
CONDITION	CONDITION	NN	I-NP	O
ON	ON	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-ADJP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
To	To	TO	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

FOLLOW-UP	FOLLOW-UP	NN	B-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Bone	Bone	NNP	B-NP	O
densitometry	densitometry	NN	I-NP	O
September	September	NNP	I-NP	O
,	,	,	O	O
1998	1998	CD	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Dr.	Dr.	NNP	B-NP	O
Clinton	Clinton	NNP	I-NP	O
Ardizone	Ardizone	NNP	I-NP	O
March	March	NNP	I-NP	O
,	,	,	O	O
1998	1998	CD	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Dr.	Dr.	NNP	B-NP	O
Win	Win	NNP	I-NP	O
in	in	IN	B-PP	O
October	October	NNP	B-NP	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
MOHAMMAD	MOHAMMAD	NNP	B-NP	O
CLEARK	CLEARK	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
FABIAN	FABIAN	NNP	B-NP	O
V.	V.	NNP	I-NP	O
POMPONI	POMPONI	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
TD2	TD2	NNP	I-NP	O
QY346/4529	QY346/4529	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
80268	80268	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

Q4EQKS3YIU	Q4EQKS3YIU	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
1/17/98	1/17/98	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
9/7/98	9/7/98	CD	B-NP	O

